Title 21 Job Opportunities
The 21st Century Cures Act was enacted on December 13, 2016 and Section 3072 of the Act grants the Commissioner of Food and Drugs the authority to appoint and set the annual rate of pay for outstanding and qualified candidates to scientific, technical, or professional positions that support the development, review, and regulation of medical products. The FY23 Food and Drug Omnibus Reform Act expanded this authority further amending Title 21 to include cross-cutting operational positions and individuals that support the development review and regulation of food and cosmetics in addition medical products. (codified into Title 21 of the United States Code (21 US Code 379d-3a).
The positions listed below are being filled under Title 21. The candidate selected for these positions will serve under a career or career-conditional appointment and be paid under the provisions of the authority. Additional information on 21st Century Cures Act can be found here
Title 21 Open Vacancies
Pharmacist
Center for Drug Evaluation and Research (CDER)
Closing date: July 15, 2023
Branch Chief, Budget Formulation Branch
Center for Food Safety and Applied Nutrition (CFSAN)
Closing date: July 18, 2023
Science Policy Analyst
Center for Drug Evaluation and Research (CDER)
Closing date: July 28, 2023
Senior Regulatory Health Project Manager
Center for Drug Evaluation and Research (CDER)
Closing date: July 14, 2023
Regulatory Counsel
Center for Drug Evaluation and Research (CDER)
Closing date: July 14,2023
Regulatory Health Project Manager
Center for Drug Evaluation and Research (CDER)
Closing date: July 13, 2023
Food Safety Advisor for Critical Foods (Interdisciplinary Scientist)
Center for Food Safety and Applied Nutrition (CFSAN)
Closing Date: July 18, 2023
Toxicologist (Senior Science Advisor Staff)
Center for Food Safety and Applied Nutrition (CFSAN)
Closing Date: July 28, 2023
Cross Discipline Safety Advisor (Physician)
Center for Drug Evaluation and Research (CDER)
Closing date: July 5, 2023
Cross Discipline Safety Advisor (General Health Scientist)
Center for Drug Evaluation and Research (CDER)
Closing date: July 5, 2023
Office Director (Supervisory Physician)
Center for Drug Evaluation and Research (CDER)
Closing date: July 10, 2023
Ombudsman
Center for Biologics Evaluation and Research (CBER)
Closing Date: July 20, 2023
Associate Director for Safety
Center for Drug Evaluation and Research (CDER)
Closing date: July 7, 2023
Urologist - Physician (OHT3)
Center for Devices and Radiological Health (CDRH)
Closing Date: July 18, 2023
Consumer Safety Officer (National Expert)
Office of Regulatory Affairs (ORA)
Closing date: July 18, 2023
Pharmacist
Center for Drug Evaluation and Research (CDER)
Closing date: June 30, 2023
Pharmaceutical Scientist (Research)
Center for Drug Evaluation and Research (CDER)
Closing date: June 30, 2023
Senior Advisor (Regulatory Counsel)
Center for Biologics Evaluation and Research (CBER)
Closing Date: July 5, 2023
Interdisciplinary Scientist (Biologist, Pharmacologist, Toxicologist)
The Center for Drug Evaluation and Research (CDER)
Closing Date: July 19, 2023
Deputy Super Office Director for Science (OTS-IO)
Center for Drug Evaluation and Research (CDER)
Closing date: June 28, 2023
International Relations Specialist
Office of the Commissioner (OC)
Closing Date: July 5, 2023
IT Specialist (Data Architect)
Center for Biologics Evaluation and Research (CBER)
Closing Date: July 28, 2023
Consumer Safety Officer - Band C
Office of the Commissioner (OC)
Closing Date: June 30, 2023
Consumer Safety Officer- Band B
Office of the Commissioner (OC)
Closing Date: June 30, 2023
Physician (Hematology)
Center for Biologics Evaluation and Research (CBER)
Closing Date: July 3, 2023
Lead Physician (Hematology)
Center for Biologics Evaluation and Research (CBER)
Closing Date: July 3, 2023
Associate Commissioner for Regulatory Affairs (ACRA)
Office of Regulatory Affairs
Closing date: July 12, 2023
Clinical Pharmacologist Reviewer, Division of Clinical Evaluation Hematology (DCEH)
Center for Biologics Evaluation and Research (CBER)
Closing Date: July 3, 2023
Physician
Center for Biologics Evaluation and Research (CBER)
Open continuously; applications will be reviewed periodically.
Physician
Center for Biologics Evaluation and Research (CBER)
Open continuously; applications will be reviewed periodically
Branch Chief, Oncology Branch 2 (OB2)
The Center for Biologics Evaluation and Research (CBER)
Closing Date: July 6, 2023